These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 15217950)

  • 41. Detection of residual neuroblastoma cells in bone marrow: comparison of flow cytometry with immunocytochemistry.
    Swerts K; De Moerloose B; Dhooge C; Brichard B; Benoit Y; Laureys G; Philippé J
    Cytometry B Clin Cytom; 2004 Sep; 61(1):9-19. PubMed ID: 15351977
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma.
    Nowecki ZI; Rutkowski P; Nasierowska-Guttmejer A; Ruka W
    Ann Surg Oncol; 2006 Dec; 13(12):1655-63. PubMed ID: 17016755
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of early-stage colorectal cancer patients at risk of relapse post-resection by immunobead reverse transcription-PCR analysis of peritoneal lavage fluid for malignant cells.
    Lloyd JM; McIver CM; Stephenson SA; Hewett PJ; Rieger N; Hardingham JE
    Clin Cancer Res; 2006 Jan; 12(2):417-23. PubMed ID: 16428481
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Malignant melanoma in Turkey: a single institution's experience on 475 cases.
    Tas F; Kurul S; Camlica H; Topuz E
    Jpn J Clin Oncol; 2006 Dec; 36(12):794-9. PubMed ID: 17060409
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Detection of melanoma cells displaying multiple genomic changes in histopathologically negative sentinel lymph nodes.
    Ulmer A; Fischer JR; Schanz S; Sotlar K; Breuninger H; Dietz K; Fierlbeck G; Klein CA
    Clin Cancer Res; 2005 Aug; 11(15):5425-32. PubMed ID: 16061857
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Contemporary surgical treatment of advanced-stage melanoma.
    Essner R; Lee JH; Wanek LA; Itakura H; Morton DL
    Arch Surg; 2004 Sep; 139(9):961-6; discussion 966-7. PubMed ID: 15381613
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Elimination of malignant tumor cells from human bone marrow using monoclonal antibodies and immunomagnetic beads.
    Wang SY; Makl KL; Chen LY; Tzeng CH; Hu CP; Chang C
    Anticancer Res; 1993; 13(6A):2281-5. PubMed ID: 8297147
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sentinel lymph node biopsy for cutaneous melanoma: the Stanford experience, 1997-2004.
    Berk DR; Johnson DL; Uzieblo A; Kiernan M; Swetter SM
    Arch Dermatol; 2005 Aug; 141(8):1016-22. PubMed ID: 16103331
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Detection of melanoma cells in the lymphatic drainage after lymph node dissection in melanoma patients by using two-marker reverse transcriptase-polymerase chain reaction assay.
    Włodzimierz R; Rutkowski P; Nowecki ZI; Kulik J; Nasierowska-Guttmejer A; Siedlecki JA
    Ann Surg Oncol; 2004 Nov; 11(11):988-97. PubMed ID: 15525828
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3).
    Nowecki ZI; Rutkowski P; Michej W
    Ann Surg Oncol; 2008 Aug; 15(8):2223-34. PubMed ID: 18506535
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunomagnetic separation for enrichment and sensitive detection of disseminated tumour cells in patients with head and neck SCC.
    Partridge M; Phillips E; Francis R; Li SR
    J Pathol; 1999 Nov; 189(3):368-77. PubMed ID: 10547599
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rapid and sensitive immunomagnetic-electrochemiluminescent detection of p53 antibodies in human serum.
    Yan G; Xing D; Tan S; Chen Q
    J Immunol Methods; 2004 May; 288(1-2):47-54. PubMed ID: 15183084
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Isolation of circulating cancer cells from whole blood by immunomagnetic cell enrichment and unenriched immunocytochemistry in vitro.
    Zigeuner RE; Riesenberg R; Pohla H; Hofstetter A; Oberneder R
    J Urol; 2003 Feb; 169(2):701-5. PubMed ID: 12544346
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nuclear survivin is associated with disease recurrence and poor survival in patients with cutaneous malignant melanoma.
    Piras F; Murtas D; Minerba L; Ugalde J; Floris C; Maxia C; Colombari R; Perra MT; Sirigu P
    Histopathology; 2007 Jun; 50(7):835-42. PubMed ID: 17543072
    [TBL] [Abstract][Full Text] [Related]  

  • 55. LightCycler-based quantitative real-time PCR monitoring of patients with follicular lymphoma receiving rituximab in combination with conventional or high-dose cytotoxic chemotherapy.
    Martin S; Fischer C; Free M; Kurreck B; Stockinger H; Fenk R; Arnold C; Kliszewski S; Meckenstock G; Haas R; Kronenwett R
    Eur J Haematol; 2005 Apr; 74(4):282-92. PubMed ID: 15777339
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression of CXCR4 predicts poor prognosis in patients with malignant melanoma.
    Scala S; Ottaiano A; Ascierto PA; Cavalli M; Simeone E; Giuliano P; Napolitano M; Franco R; Botti G; Castello G
    Clin Cancer Res; 2005 Mar; 11(5):1835-41. PubMed ID: 15756007
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular staging by multimarker reverse transcriptase-polymerase chain reaction assay of lymphatic drainage and blood from melanoma patients after lymph node dissection.
    Rutkowski P; Nowecki ZI; Kulik J; Ruka W; Siedlecki JA
    Melanoma Res; 2008 Aug; 18(4):246-52. PubMed ID: 18626308
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tumor-cell homing to lymph nodes and bone marrow and CXCR4 expression in esophageal cancer.
    Kaifi JT; Yekebas EF; Schurr P; Obonyo D; Wachowiak R; Busch P; Heinecke A; Pantel K; Izbicki JR
    J Natl Cancer Inst; 2005 Dec; 97(24):1840-7. PubMed ID: 16368946
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cellular proliferation and prevalence of micrometastatic cells in the bone marrow of patients with clinically localized prostate cancer.
    Cher ML; de Oliveira JG; Beaman AA; Nemeth JA; Hussain M; Wood DP
    Clin Cancer Res; 1999 Sep; 5(9):2421-5. PubMed ID: 10499613
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunobead-based detection and characterization of circulating tumor cells in melanoma patients.
    Fodstad O; Faye R; Høifødt HK; Skovlund E; Aamdal S
    Recent Results Cancer Res; 2001; 158():40-50. PubMed ID: 11092032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.